We unpack how the rise of GLP-1 medications is reshaping consumer behaviour, from smaller, more intentional purchases to a growing demand for high-protein, low-sugar, nutrient-dense foods without compromising on taste. As this "new consumer" continues to grow, manufacturers face the challenge of balancing nutrition, functionality, and indulgence all within a smaller serving size.
Author: Anneri Carinus, Marketing Manager




